Dashboard
1
Poor Management Efficiency with a low ROCE of 9.67%
- The company has been able to generate a Return on Capital Employed (avg) of 9.67% signifying low profitability per unit of total capital (equity and debt)
2
Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.15 times
3
Poor long term growth as Operating profit has grown by an annual rate -5.51% of over the last 5 years
4
Flat results in Dec 24
5
Risky - Not traded in last 10 days
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.2%
0%
5.2%
6 Months
40.5%
0%
40.5%
1 Year
95.47%
0%
95.47%
2 Years
-7.31%
0%
-7.31%
3 Years
-41.71%
0%
-41.71%
4 Years
-30.43%
0%
-30.43%
5 Years
-12.57%
0%
-12.57%
Alliance Pharma Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.69%
EBIT Growth (5y)
-5.51%
EBIT to Interest (avg)
6.68
Debt to EBITDA (avg)
2.15
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
0.44
Tax Ratio
25.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.67%
ROE (avg)
11.04%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.71
EV to EBIT
14.66
EV to EBITDA
10.93
EV to Capital Employed
1.55
EV to Sales
2.33
PEG Ratio
NA
Dividend Yield
9826.62%
ROCE (Latest)
10.59%
ROE (Latest)
12.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2021
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 110 Foreign Institutions (33.59%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
167.40
163.20
2.57%
Operating Profit (PBDIT) excl Other Income
39.60
48.10
-17.67%
Interest
5.40
3.60
50.00%
Exceptional Items
-18.20
-16.50
-10.30%
Consolidate Net Profit
0.90
7.30
-87.67%
Operating Profit Margin (Excl OI)
172.00%
233.10%
-6.11%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 2.57% vs 25.73% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -87.67% vs -8.75% in Dec 2021
About Alliance Pharma Plc 
Alliance Pharma Plc
Pharmaceuticals: Major
No Details Available.
Company Coordinates 
No Company Details Available






